Dr U'Prichard joins Ocimum's board
This article was originally published in Scrip
Executive Summary
David U'Prichard, president of Druid Consulting LLC, has joined the board of Ocimum Biosolutions, a genomics solutions company in India. Dr U'Prichard holds board positions in several companies including Life Technologies, Oxagen, Cyclacel and Silence Therapeutics. He is also a partner at Red Abbey Venture Partners, and was chairman of R&D at SmithKline Beecham from 1997 to 1999, among other senior positions he has held in prior stints in the industry.